Microglia specific alternative splicing alterations in multiple sclerosis

Caiyun Qi1, Honglei Ren2, Yong Fan1

  • 1Department of Obstetrics and Gynecology; Guangdong Provincial Key Laboratory of Major Obstetric Diseases; Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology; Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine; The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.

Aging
|August 8, 2024
PubMed

Insights

This study reveals cell-type specific alternative splicing (AS) changes in microglia from multiple sclerosis (MS) patients. These findings highlight novel molecular mechanisms in MS white matter pathology.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Aberrant alternative splicing (AS) is implicated in multiple sclerosis (MS) pathogenesis.
  • Cell-type specific AS events in MS remain underexplored, particularly in microglia.

Purpose of the Study:

  • To investigate cell-type specific alternative splicing (AS) events in microglia from the white matter of MS patients.
  • To identify novel molecular pathways and potential therapeutic targets in MS.

Main Methods:

  • Utilized RNA-sequencing data from sorted CD15-CD11b+ microglia of MS patients and controls.
  • Applied rMATS to identify five types of AS events: A3SS, A5SS, SE, RI, and MXE.
  • Performed differential gene expression analysis and Gene Ontology (GO) enrichment analysis.

Main Results:

  • Identified 132 significant AS events in microglia from MS patients.
  • Skipped exon (SE) was the most prevalent AS event, followed by mutually exclusive exons (MXE) and retained introns (RI).
  • Genes involved in telomere maintenance (SE), protein folding/mitochondrion organization (MXE), and immune response (RI) showed distinct AS patterns.

Conclusions:

  • Discovered microglia-specific AS alterations in the white matter of MS patients.
  • These AS changes may contribute to MS pathogenesis.
  • Provides insights into novel pathological mechanisms and potential therapeutic strategies for MS.